ESC 365 - Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7

Back

ESC Premium Access

Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy.

Session: Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor C. Fumagalli (Florence, IT)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Carlo Fumagalli

Careggi University Hospital (AOUC), Florence (Italy)

0 follower

5 more presentations in this session

Survival after septal myectomy in male and female patients with hypertrophic obstructive cardiomyopathy

Speaker: Mr R. Huurman (Rotterdam, NL)

Access

Abstract

Slides

In a prospective randomized study in familial hypertrophic cardiomyopathy, metoprolol maintains exercise-performance, with lower myocardial oxygen-cost, and prevents deterioration in exercise-ability

Speaker: Professor I. Ostman-Smith (Gothenburg, SE)

Access

Abstract

Slides

Myocardial transit time (MTT) - a novel and easy-to-perform CMR parameter to assess microvascular disease.

Speaker: Mr G. Chatzantonis (Munster, DE)

Access

Abstract

Slides

FLNC pathogenic variants in patients with various cardiomyopathies:prevalence and genotype-phenotype correlations

Speaker: Doctor F. Ader (Paris, FR)

Access

Abstract

Slides

Characteristics and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy

Speaker: Doctor K. Choi (Seoul, KR)

Access

Abstract

Slides

Access the full session

Clinical, imaging and genetic advances in hypertrophic cardiomyopathy

Speakers: Doctor C. Fumagalli, Mr R. Huurman, Professor I. Ostman-Smith, Mr G. Chatzantonis, Doctor F. Ader...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources